NCT00047099View on ClinicalTrials.gov

Combination Chemotherapy in Treating Women With Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

446

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

February 29, 2012

Study Completion Date

March 31, 2012

Conditions
Breast Cancer
Interventions
DRUG

cyclophosphamide

DRUG

docetaxel

DRUG

epirubicin hydrochloride

DRUG

fluorouracil

DRUG

goserelin acetate

DRUG

tamoxifen citrate

PROCEDURE

adjuvant therapy

RADIATION

radiation therapy

Trial Locations (2)

D-80337

I. Frauenklinik und Hebammenschule der Ludwig-Maximillians Universitaet Muenchen, Munich

D-81675

Klinikum Rechts Der Isar - Technische Universitaet Muenchen, Munich

All Listed Sponsors
lead

Ludwig-Maximilians - University of Munich

OTHER

NCT00047099 - Combination Chemotherapy in Treating Women With Breast Cancer | Biotech Hunter | Biotech Hunter